{"meta":{"query_hash":"117fabb84f3f","filters":{"venue":"Archives of Oncology and Cancer Therapy"},"cohort_total":1,"direct_labels_cover":0,"predictions_cover":1,"exported":1,"export_cap":100000,"truncated":false,"label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"permalink":"https://metacan.xera.ac/q/117fabb84f3f","api":"https://metacan.xera.ac/api/v1/cohort?venue=Archives+of+Oncology+and+Cancer+Therapy"},"results":[{"id":"W4386175661","doi":"10.22259/2638-5074.0101005","title":"Patent and Publications Trends in Breast Cancer Chemotherapy","year":2018,"lang":"en","type":"article","venue":"Archives of Oncology and Cancer Therapy","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Instituto Mexicano del Seguro Social","keywords":"Breast cancer; Oncology; Chemotherapy; Medicine; Internal medicine; Cancer","score_opus":0.03782662346253245,"score_gpt":0.3540970565709901,"score_spread":0.31627043310845765,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386175661","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94868183,0.012939751,0.00010028112,0.034532856,0.00010985176,0.00022104854,0.000068146284,0.000033000077,0.0033132574],"genre_scores_gemma":[0.9572055,0.038241558,0.0007937243,0.0025031907,0.00024052165,0.00018796188,0.000006720497,0.000021798776,0.0007990237],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99916804,0.000044238517,0.0002091507,0.00027710223,0.00007721498,0.00022428109],"domain_scores_gemma":[0.999508,0.0000646221,0.000107340806,0.0001749218,0.000048181035,0.00009693355],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000069440706,0.00014244669,0.00033874743,0.00024786766,0.000063642256,0.000005039023,0.000074494645,0.000069300455,0.00059877546],"category_scores_gemma":[0.000001835467,0.00011452282,0.00004016927,0.00022070705,0.0008607354,0.00008291512,0.000022606459,0.00013641977,4.5735018e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002347677,0.00016777606,0.15216757,0.0000123285445,0.00011788013,0.0000011828106,0.002766934,9.258698e-7,0.019425731,0.00036492455,0.000056284076,0.8225708],"study_design_scores_gemma":[0.00624828,0.00067029055,0.9026301,0.000075359916,0.000018422741,0.00006762621,0.00018044905,0.000070611146,0.0029686403,0.0014690777,0.08548038,0.00012076047],"about_ca_topic_score_codex":0.00043024894,"about_ca_topic_score_gemma":0.0003530658,"teacher_disagreement_score":0.82245004,"about_ca_system_score_codex":0.00004907998,"about_ca_system_score_gemma":0.00014556384,"threshold_uncertainty_score":0.6556171},"labels":[],"label_agreement":null}]}